The Patient Derived Xenograft (PDX) Models Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for patient derived xenograft (PDX) models has seen considerable growth lately. In 2024, it was valued at $0.4 billion and is projected to increase to $0.47 billion by 2025, reflecting a compound annual growth rate (CAGR) of 16.4%.
The Patient Derived Xenograft (PDX) Models market is projected to reach a size of $0.85 billion by 2029, growing at a compound annual growth rate of 16.0%.
Download Your Free Sample of the 2025 Patient Derived Xenograft (PDX) Models Market Report and Uncover Key Trends Now!The drivers in the patient derived xenograft (pdx) models market are:
• Increasing investments in research and development
• Regulatory support for the PDX models market
• Rise in partnerships and collaborations in the industry
• Growth of contract research organizations and prevalent cancer cases
The patient derived xenograft (PDX) models market covered in this report is segmented –
1) By Type: Mice Models, Rat Models
2) By Technique: Heterotopic Implantation, Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models
4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research
5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users
The trends in the patient derived xenograft (pdx) models market are:
• Technological developments are constantly emerging in the PDX models market.
• There is rising demand for humanized PDX models.
• Collaborative research initiatives are becoming a significant trend.
• Increasing focus on immuno-oncology is shaping the market's future.
The major players in the patient derived xenograft (pdx) models market are:
• Laboratory Corporation of America Holdings
• WuXi AppTec Co.
North America was the largest region in the patient derived xenograft (PDX) models market in 2023